SARS-CoV-2 detection and genomic surveillance: moving to ensure accessible tools in low-income and middle-income countries

Lancet Microbe. 2024 Sep;5(9):100896. doi: 10.1016/S2666-5247(24)00128-9. Epub 2024 Jun 6.

Author

Severino Jefferson Ribeiro da Silva¹

Affiliation

¹ Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada. Electronic address: [email protected].

PMID: 38852605
DOI: 10.1016/S2666-5247(24)00128-9

No abstract available

MeSH terms

COVID-19* / epidemiology
Developing Countries*
Genome, Viral
Genomics / methods
Humans
SARS-CoV-2* / genetics